Ruetzler Kurt, Montalvo Mateo, Bakal Omer, Essber Hani, Rössler Julian, Mascha Edward J, Han Yanyan, Ramachandran Mangala, Keebler Allen, Turan Alparslan, Sessler Daniel I
From the Departments of Outcomes Research.
General Anesthesiology.
Anesth Analg. 2023 Apr 1;136(4):761-771. doi: 10.1213/ANE.0000000000006351. Epub 2023 Jan 20.
Nociception is the physiological response to nociceptive stimuli, normally experienced as pain. During general anesthesia, patients experience and respond to nociceptive stimuli by increasing blood pressure and heart rate if not controlled by preemptive analgesia. The PMD-200 system from Medasense (Ramat Gan, Israel) evaluates the balance between nociceptive stimuli and analgesia during general anesthesia and generates the nociception level (NOL) index from a single finger probe. NOL is a unitless index ranging from 0 to 100, with values exceeding 25 indicating that nociception exceeds analgesia. We aimed to demonstrate that titrating intraoperative opioid administration to keep NOL <25 optimizes intraoperative opioid dosing. Specifically, we tested the hypothesis that pain scores during the initial 60 minutes of recovery are lower in patients managed with NOL-guided fentanyl than in patients given fentanyl per clinical routine.
We conducted a randomized, single-center trial of patients having major abdominal open and laparoscopic surgeries. Patients were randomly assigned 1:1 to intraoperative NOL-guided fentanyl administration or fentanyl given per clinical routine. The primary outcome was pain score (0-10 verbal response scale) at 10-minute intervals during the initial 60 minutes of recovery. Our secondary outcome was a measure of adequate analgesia, defined as a pain score <5, assessed separately at each interval.
With a planned maximum sample size of 144, the study was stopped for futility after enrolling 72 patients from November 2020 to October 2021. Thirty-five patients were assigned to NOL-guided analgesic dosing and 37 to routine care. Patients in the NOL group spent significantly less time with a NOL index >25 (median reduction [95% confidence interval {CI}] of 14 [4-25] minutes) were given nearly twice as much intraoperative fentanyl (median [quartiles] 500 [330, 780] vs 300 [200, 330] µg), and required about half as much morphine in the recovery period (3.3 [0, 8] vs 7.7 [0, 13] mg). However, in the primary outcome analysis, NOL did not reduce pain scores in the first 60 minutes after awakening, assessed in a linear mixed effects model with mean (standard error [SE]) of 4.12 (0.59) for NOL and 4.04 (0.58) for routine care, and estimated difference in means of 0.08 (-1.43, 1.58), P = .895.
More intraoperative fentanyl was given in NOL-guided patients, but NOL guidance did not reduce initial postoperative pain scores.
伤害感受是对伤害性刺激的生理反应,通常表现为疼痛。在全身麻醉期间,如果没有预先镇痛的控制,患者会通过升高血压和心率来感受并对伤害性刺激做出反应。Medasense公司(以色列拉马特甘)的PMD - 200系统可评估全身麻醉期间伤害性刺激与镇痛之间的平衡,并通过单个手指探头生成伤害感受水平(NOL)指数。NOL是一个无量纲指数,范围从0到100,值超过25表明伤害感受超过镇痛效果。我们旨在证明,滴定术中阿片类药物给药以使NOL <25可优化术中阿片类药物剂量。具体而言,我们检验了以下假设:与按照临床常规给予芬太尼的患者相比,接受NOL引导的芬太尼治疗的患者在恢复最初60分钟内的疼痛评分更低。
我们对接受大型腹部开放手术和腹腔镜手术的患者进行了一项随机、单中心试验。患者按1:1随机分配接受术中NOL引导的芬太尼给药或按照临床常规给予芬太尼。主要结局是恢复最初60分钟内每隔10分钟的疼痛评分(0 - 10语言反应量表)。我们的次要结局是充分镇痛的指标,定义为疼痛评分<5,在每个时间间隔分别评估。
计划的最大样本量为144,在2020年11月至2021年10月招募了72名患者后,该研究因无效而停止。35名患者被分配接受NOL引导的镇痛给药,37名患者接受常规护理。NOL组患者NOL指数>25的时间显著减少(中位数降低[95%置信区间{CI}]为14[4 - 25]分钟),术中给予的芬太尼几乎是常规护理组的两倍(中位数[四分位数间距]500[330, 780] vs 3,00[200, 330]μg),并且在恢复期所需的吗啡量约为常规护理组的一半(3.3[0, 8] vs 7.7[0, 13]mg)。然而,在主要结局分析中,在苏醒后的前60分钟,NOL并未降低疼痛评分,在线性混合效应模型中评估,NOL组的均值(标准误[SE])为4.12(0.59),常规护理组为4.04(0.58),均值估计差异为0.08(-1.43, 1.58),P = 0.895。
接受NOL引导的患者术中给予了更多芬太尼,但NOL引导并未降低术后初始疼痛评分。